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Abstract 
Background : Disorder of sex development (DSD) patients require comprehensive 
management to improve quality of life. A standardized management protocol for 
patients in Indonesia is not yet available resulting in patients infrequently received 
a proper diagnosis and appropriate gender assignment.  
Objectives : The purpose of the study was to report the management of DSD 
patients in Indonesia with regards to minimal diagnostic facilities and expertise in 
developing country.  
Methodology : We analyzed DSD patients managed by Sexual Adjustment 
Multidisciplinary Team (SAT) through the record at Center for Biomedical 
Research Faculty of Medicine Diponegoro University, from May 2004 - December 
2015 and bimonthly multidisciplinary SAT meeting. The team was consist of 
endocrinologist, andrologist, urologist, plastic surgeon, gynaecologist, 
anesthesiologist, medical geneticist, psychiatrist, psychologist, pathology, legal 
medicine, religion and social-medical staffs. Data were grouped by diagnosis that 
based on physical examination, family pedigree, karyotyping, hormonal assays and 
other examination such as ultrasonography, X-ray, and cytoscopy for selected 
cases.  
Results : From the total of 617 cases we found 426 cases with 46,XY DSD (69.04 
%), 117 cases  with 46,XX DSD (18.96%), and 74 cases  with sex chromosome 
DSD (12%). Most of the patients in the group of 46,XY DSD were Unknown Male 
Undervirilization (60.09%) followed by Congenital Adrenal Hyperplasia (69.23%) 
in 46, XX DSD group. 
Conclusion : Comprehensive management for DSD Patients help patient in 
diagnosis, gender assignment and support patient to improve quality of life. This 
multidisciplinary of DSD team is the only team in Indonesia that can be used as a 
model for other center in Indonesia as well as other developing countries with 
minimal diagnostic facilities.  
 
Keywords: Disorder of Sex Development (DSD); Sexual Adjustment Team; 
Chromosome. 
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INTRODUCTION 
 Disorder of Sex Development (DSD) is defined 
by congenital conditions in which development of 
chromosomal, gonadal, or anatomical sex is atypical.
1
 
This broad category is divided into three primary 
roots based on karyotype namely 46,XY DSD; 46,XY 
DSD and Sex Chromosome DSD. Secondary root is 
depicted based on hormone assessment and imaging, 
while the tertiary root is obtained based on molecular 
and/or histopathology examination. 
 In Indonesia, it is very rare to have a complete 
diagnosis procedure where molecular evaluation is 
needed for DSD confirmation. Molecular analysis as 
part of health care services is limited to research 
center of the universities in big cities. Early diagnosis 
and integrated treatment are important for DSD 
patients, in order to anticipate the proper treatment 
and gender assignment within medical, psychological 
and social aspect through the gender team.  
 A number of studies from different countries and 
cultural differences showed that while many patients 
managed sequentially, gender counseling, as well as 
sexual counseling, should be the part of multi-
disciplinary service available to patients with DSD to 
avoid gender dysphoria.
2,3
 The aim of this study is to 
review the management of  DSD patients in Indonesia 
as a developing country related to providing 
appropriate gender assignment and to improving 
patients quality of life.  
 
METHODOLOGY  
 The formation of Sexual Adjustment 
Multidisciplinary Team (SAT) since 1989,  is the 
only team available in Indonesia with the members 
from Dr. Kariadi Hospital and Faculty of Medicine 
Diponegoro University (FMDU), which consists of 
specialists from various departments : urology, plastic 
surgery, gynecology, endocrinology, andrology, 
anesthesiology, genetics, psychiatry, pathology, 
psychology, legal medicine, religion and social-
medical staffs. The purpose of the Team is to provide 
the following comprehensive care for families and 
individuals with DSD.  
 The activities performed by SAT are bimonthly 
meetings, special multidisciplinary meetings for case 
discussion of about 5-10 cases, clinical and laboratory 
examination, patient’s home visits, scientific 
meetings and overseas collaboration for research 
project.  
 We analyzed DSD patients managed by SAT  
through the record and bimonthly multidisciplinary 
SAT meeting at Center for Biomedical Research 
Faculty of Medicine Diponegoro University,  from 
May 2004 - December 2015. Data were grouped by 
diagnosis based on new DSD classification by 
Hughes.
4
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 Diagnosis was established by physical 
examination, family pedigree, karyotyping, hormonal 
assays, and other examination such as 
ultrasonography, X-ray, and Cytoscopy for selected 
cases. The patients were referred by clinicians from 
the department of urology, pediatrics, internal 
medicine, obstetrics, and member of sexual 
adjustment team. The reason for referral was the 
presence of ambiguous genitalia or any anatomical 
abnormality of external or internal genitalia. 
However, a few may present with delayed puberty or 
primary amenorrhea. Each patients with genital 
disorder is referred to the SAT member, with the goal 
of establishing the chromosomal sex, the gonadal sex, 
and the phenotypic sex (appearance of the external 
and internal genitalia) to determine the underlying 
diagnosis. 
 Approval from the medical ethics committee of 
FMDU and informed consent from all participants, or 
parents / guardians prior to their participation in this 
study were obtained. 
 
RESULT 
 A total of 617 DSD patients were evaluated by 
SAT member. The age of patients were ranging from 
2 days to 44 years old. Patients referred after the age 
of one year and adults were dominant among our 
patients (see table 1). Patients data were categorized 
according to their diagnosis; 426 cases (69.04 %) 
with 46,XY DSD, 117 cases (18.96%) with 46,XX 
DSD and 74 cases (12 %) with sex chromosome DSD 
(Figure 1). Most of the patients in the group of 
46,XY DSD were 256 cases (60.09%) with Unknown 
Male Undervirilization (UMU) (Figure 2) and in the 
group 46,XX DSD were 81 cases (69.23%) with 
Congenital Adrenal Hyperplasia. (Figure 3).  
The remaining cases of 46,XY DSD group 
were 140 cases (32.86%) with Androgen Action 
Disorder (AAD) and 30 cases (7.04%) with Gonadal 
Dysgenesis, while  46, XX DSD groups were 
Androgen Excess Disorders 3 cases (2.56%), Defect 
of Mullerian Development with 19 cases (16,24%), 3 
cases (2.56%) of Androgen Excess, 3 cases (2.56%) 
of 46, XX DSD Gonadal Dysgenesis And 74 cases 
with Sex Chromosome DSD.  
 
DISCUSSION 
 The SAT in our center is the only 
multidisciplinary team for managing DSD cases so 
far.  The medical management approach to DSD is 
based on the belief that DSD is pathological and 
devalues the experience of affected individuals. The 
management of DSD must always be undertaken on a 
case-by-case basis with the goal of maximizing long-
term physical and psychological outcomes for 
individuals with DSD.
5
 Patient came from different 
region of Indonesia with different tribe, culture and 
religion, therefore management DSD in Indonesia 
should be carried out individually.  
 In Indonesia, as well as in South Asian countries, 
genetic counselor as health care provider is not very 
common, therefore clinical physicians would have to 
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deal with patients and family members by their own 
way quite often.
6
 The majority cases of 46, XX DSD 
was Congenital Adrenal Hyperplasia (CAH) (81 
cases) which required immediate comprehensive 
treatment because its nature of the crisis often leads to 
a life-threatening situation. Unfortunately, most of the 
medication for CAH is not available in Indonesia. 
Donation based on research was obtained from our 
collaborator such Erasmus University Medical Center 
Rotterdam, The Netherlands.  
 DSD is a broad term that describes a large variety 
of phenotype with disturbed development of internal 
and external genitalia, which is the result of various 
events occurring during sex differentiation. There are 
potentially novel genes and alternative pathways may 
play that lead to gonadal formation and 
differentiation, it is not always possible to identify the 
causes of the disorders.
7–9
 
 
Consequently, the scope of 
molecular genetic analysis has markedly expanded. In 
Indonesia laboratory with molecular diagnosis 
facilities is very rare and advanced molecular testing 
are only available in big cities. Although clinical and 
psychological management have already been done, 
many undiagnosed DSD should be later analyzed 
using advanced molecular techniques.
10
 
 The wide spectrum of the clinical presentation of 
DSD is another aspect, and the interval of detection 
from the antenatal period into childhood or 
adolescence is also a factor to consider.
11,12
 Financial 
resources, health insurance issues, social, and cultural 
variables can also influence the attitudes of the 
parents for gender preference of the newborn or child 
with DSD. Because of National Health Insurance 
(JKN) cannot cover for diagnostic testing and 
treatment of DSD, the funds sometimes came  from 
fund rising. This is become big issues for patients and 
family. They should consider whether they have 
sufficient funds to undergo therapy. The distances to 
a referral hospital is the second issue that must be 
faced by patients and their families. The long distance 
means they have to leave their families at home and 
they can not go to work while going for medical 
consultation and treatment. They must consider not 
only the decision from him/ herself, but also must 
consider the decision of the whole family. 
 Many patients come in late condition with 
physical and psychological complex dilemma. In 
many of underprivileged Asian countries, a child born 
with ambiguous genitalia grow up while bearing the 
congenital anatomic sex features, which remain 
untreated in the form of surgical treatment until 
adolescences or adulthood.
2,3,13 
 
 Psychological evaluation was done by our group 
in the previous study to identify the concerns of the 
parents of a newborn with ambiguous genitalia and 
provide support for the accompanying uncertainty.
14
 
This evaluation includes an assessment of parents’ 
expectations regarding the gender of their baby, their 
understanding of what they have been told since the 
baby’s birth, and their preferences, particularly within 
the context of their cultural and religious background, 
as well as a general assessment of coping strategies.
14
 
Adult untreated patients either they already changed 
their gender or still undecided gender were suffered 
from stigmatization and gender dysphoria and need 
thorough psychological assessment.
15–17
 Culture is an 
important part of the context in which decisions are 
made on sex assignment. Attitudes concerning gender 
and sexuality, including the acceptance of 
intersexuality, may differ between various cultures.
2,6
 
In our study, cultural differences as well as religion in 
dealing with DSD individuals not only influence the 
patient's own psychosexual development but also 
medical decisions regarding sex assignment and 
consecutive management.  
 The majority of well-established diagnosis were 
Androgen Insensitivity Syndrome and Congenital 
Adrenal Hyperplasia. These diagnoses already been 
proven by AR gene and CYP 21 mutation in 46, XY 
and 46, XX DSD respectively.
18
 
In Indonesia, diagnosis and management of DSD 
patients have not received attention they deserve, 
since infectious disease is still a priority as the major 
cause of death. The first multidisciplinary approach 
on DSD management conducted in Indonesia is held 
in our center. Once we provided a multidisciplinary 
service and publicized to the community, a lot of 
patients came for consultation. Lacks of expertise, 
laboratory equipment and financial burden, as well as 
awareness of medical personnel and community were 
slow down its developments. The genital abnormality 
seems culturally taboo for some ethnic group to be 
disclosed to the family and medical personnel. The 
accountable general guideline of DSD management 
should be set and standardized nationally; hence it 
will provide adjustable implementation for the 
various conditions of patients and their families. 
Therefore, DSD management should be employed 
differently along with the diversity of cultural and 
demographic background in the societies.  
 Understanding on this issue, including an 
extensive research of patients and identify the 
structure of each ethnic and cultural background is 
necessary for general medical community in 
Indonesia in the management of patients with DSD 
complex.  This report is expected to contribute to 
DSD patients, suggestions, advice or 
recommendations on what is needed in the diagnosis 
and management of DSD which will ultimately 
improve the quality of medical care and quality of life 
of DSD patients in Indonesia. Recognition, support, 
caring and providing the medication from the 
government should be soon become reality. 
 
CONCLUSION  
 Comprehensive management for DSD Patients 
help patient in diagnosis, gender assignment and 
support patient to improve quality of life. To the best 
of our knowledge, this multidisciplinary of DSD team 
is the only team in Indonesia that can be used as a 
model for other center in Indonesia as well as other 
developing countries with minimal diagnostic 
facilities.  
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Table 1. Age distribution of DSD patients at the time of referral 
More than half of patients came to our clinic at later age (more than 1 years old). 
 
Age of referral 
DSD Patients 
Frequency (n) Percentage (%)  
< 6 months old 74 11.99  
6 months old – < 1 year old 33 5.35  
 1 year old – < 5 year old 169 27.39 
 5 year old – < 10 year old 115 18.64 
10 year old – < 15 year old 107 17.34 
> = 15 year old  119 19.29 
Total 617 100 
 
 
Figure 1 . DSD Clasification  
Six hundred and seventeen patients with various form of DSD were evaluated in our center. All the patients 
were categorized based on chromosome analysis result. There are 426 cases (69,04 %) with 46, XY DSD, 117 
cases (18,96%) with 46,XX DSD and 74 cases (12 %) with sex chromosome DSD. 
 
Figure 2. Distribution of 46,XY DSD patients  
Most patients were UMU (60, 09%) followed  by Androgen Action Disorders (32.86%) and Gonadal 
Dysgenesis (7.04%)  
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Figure 3. Distribution of  46, XX DSD  
Most patients were Congenital Adrenal Hyperplasia  (69.23%)followed by Defect of Mullerian Development 
(16.24%); Androgen Excess (2.56%)  and Gonadal Dysgenesis  (2.56%). 
 
 
